Are Your Testosterone Labs Flawed? Understanding the Science with Shimon Lobel

Testosterone laboratory results are introduced as a frequent source of confusion for diagnosis and ongoing management. The clinician emphasizes that lab numbers can vary even when physiology feels stable and consistent. Assay selection is positioned as a major driver, because different methods measure hormones differently. Immunoassays are discussed as common tests that can be convenient yet less consistent at certain ranges. LCMS testing is described as a more specific approach that some labs use for improved measurement fidelity. Rather than trusting one result blindly, the discussion encourages understanding what the test actually measures. The overall framing treats laboratory data as signals that require context to become clinically meaningful.

Free testosterone is discussed as a separate challenge because measurement approaches vary widely across laboratories. Calculated free values are mentioned as one pathway, and method assumptions are highlighted as sources of disagreement. Direct testing approaches are contrasted with calculated approaches to show why results may not match perfectly. Timing is emphasized, including morning blood draws, because hormone levels can shift during daily rhythms. Consistent collection routines are encouraged so trends reflect biology rather than scheduling or preparation differences. When comparing results, the presenter cautions against treating numbers from different methods as interchangeable. The message is that method awareness and repeat testing improve confidence more than one isolated measurement.

Differences between major labs are discussed, using examples like Quest and Labcorp to illustrate reporting variability. Reference methods and instrument differences are framed as practical reasons why two reports can diverge. Clinical interpretation is emphasized by connecting symptoms with lab signals rather than focusing only on thresholds. Endocrine signaling is explained as hormone messaging, meaning patterns matter more than a single data point. Additional monitoring is referenced, including CBC and lipid checks, to keep safety context in view. Communication strategy is encouraged, focusing on documenting methods and conditions so follow-up comparisons are fair. The closing reinforces a practical approach: choose appropriate methods, standardize timing, and interpret trends cautiously.